{"id":610606,"date":"2026-11-06T23:44:10","date_gmt":"2026-11-06T23:44:10","guid":{"rendered":"https:\/\/onle2023.excelentacj.ro\/?p=610606"},"modified":"2026-11-06T23:44:10","modified_gmt":"2026-11-06T23:44:10","slug":"lapatinib-ciklus-hatekonysag-es-alkalmazas","status":"publish","type":"post","link":"https:\/\/onle2023.excelentacj.ro\/index.php\/2026\/11\/06\/lapatinib-ciklus-hatekonysag-es-alkalmazas\/","title":{"rendered":"Lapatinib ciklus: Hat\u00e9konys\u00e1g \u00e9s alkalmaz\u00e1s"},"content":{"rendered":"

A lapatinib ciklus egy olyan kezel\u00e9si forma, amelyet a r\u00e1k k\u00fcl\u00f6nb\u00f6z\u0151 t\u00edpusainak \u2013 k\u00fcl\u00f6n\u00f6sen a mellr\u00e1knak \u2013 a kezel\u00e9s\u00e9re haszn\u00e1lnak. A lapatinib egy c\u00e9lzott ter\u00e1pia, amely a HER2 receptor g\u00e1tl\u00e1s\u00e1val m\u0171k\u00f6dik, ez\u00e1ltal g\u00e1tolja a r\u00e1ksejtek szaporod\u00e1s\u00e1t \u00e9s terjed\u00e9s\u00e9t. A lapatinib alkalmaz\u00e1sa sor\u00e1n \u00e1ltal\u00e1ban meghat\u00e1rozott ciklusokat k\u00f6vetnek, amelyek sor\u00e1n a gy\u00f3gyszert or\u00e1lis \u00faton, naponta egy alkalommal kell bevenni.<\/p>\n

Lapatinib ciklus hat\u00e9konys\u00e1g \u00e9s alkalmaz\u00e1s<\/a><\/p>\n

1. A lapatinib hat\u00e1smechanizmusa<\/h2>\n

A lapatinib a HER2\/neu receptor g\u00e1tl\u00e1s\u00e1val fejt ki hat\u00e1st. E receptorok a r\u00e1ksejtek felsz\u00edn\u00e9n tal\u00e1lhat\u00f3k, \u00e9s akt\u00edv szerepet j\u00e1tszanak a sejtek n\u00f6veked\u00e9s\u00e9ben \u00e9s szaporod\u00e1s\u00e1ban. A lapatinib megakad\u00e1lyozza, hogy a receptorok aktiv\u00e1l\u00f3djanak, ezzel lass\u00edtva vagy meg\u00e1ll\u00edtva a daganatok n\u00f6veked\u00e9s\u00e9t.<\/p>\n

2. A lapatinib alkalmaz\u00e1sa<\/h2>\n
    \n
  1. Indik\u00e1ci\u00f3:<\/strong> A lapatinib alkalmaz\u00e1sa els\u0151sorban azokn\u00e1l a betegeknek javasolt, akikn\u00e9l a HER2 pozit\u00edv mellr\u00e1k diagn\u00f3zisa m\u00e1r meg\u00e1llap\u00edt\u00e1sra ker\u00fclt.<\/li>\n
  2. D\u00f3zis:<\/strong> A szok\u00e1sos adag napi 1250 mg, amelyet or\u00e1lis k\u00e9sz\u00edtm\u00e9ny form\u00e1j\u00e1ban kell szedni.<\/li>\n
  3. Ter\u00e1pi\u00e1s ciklusok:<\/strong> A kezel\u00e9st ciklusokban v\u00e9gzik, amelyeket rendszeresen fel\u00fclvizsg\u00e1lnak a mell\u00e9khat\u00e1sok \u00e9s a hat\u00e9konys\u00e1g f\u00fcggv\u00e9ny\u00e9ben.<\/li>\n<\/ol>\n

    3. A kezel\u00e9s mell\u00e9khat\u00e1sai<\/h2>\n

    Mint minden gy\u00f3gyszernek, a lapatinibnek is lehetnek mell\u00e9khat\u00e1sai. A leggyakoribbak k\u00f6z\u00e9 tartozik a hasmen\u00e9s, b\u0151rki\u00fct\u00e9s, f\u00e1radts\u00e1g \u00e9s \u00e9tv\u00e1gytalans\u00e1g. A betegeknek javasolt, hogy a kezel\u00e9st k\u00f6vet\u0151en figyelj\u00e9k a saj\u00e1t eg\u00e9szs\u00e9gi \u00e1llapotukat, \u00e9s t\u00e1j\u00e9koztass\u00e1k az orvost b\u00e1rmilyen szokatlan t\u00fcnet eset\u00e9n.<\/p>\n

    4. K\u00f6vetkeztet\u00e9sek<\/h2>\n

    A lapatinib ciklus hat\u00e9kony m\u00f3dszer a HER2 pozit\u00edv mellr\u00e1k kezel\u00e9s\u00e9re, amely c\u00e9lzott ter\u00e1pi\u00e1t ny\u00fajt a betegek sz\u00e1m\u00e1ra. A megfelel\u0151 alkalmaz\u00e1s \u00e9s a szakmai fel\u00fcgyelet r\u00e9v\u00e9n sok betegnek seg\u00edthet a betegs\u00e9g kezel\u00e9s\u00e9ben \u00e9s a t\u00fal\u00e9l\u00e9si es\u00e9lyeik n\u00f6vel\u00e9s\u00e9ben.<\/p>\n","protected":false},"excerpt":{"rendered":"

    A lapatinib ciklus egy olyan kezel\u00e9si forma, amelyet a r\u00e1k k\u00fcl\u00f6nb\u00f6z\u0151 t\u00edpusainak \u2013 k\u00fcl\u00f6n\u00f6sen a mellr\u00e1knak \u2013 a kezel\u00e9s\u00e9re haszn\u00e1lnak. A lapatinib egy c\u00e9lzott ter\u00e1pia, amely a HER2 receptor g\u00e1tl\u00e1s\u00e1val m\u0171k\u00f6dik, ez\u00e1ltal g\u00e1tolja a r\u00e1ksejtek szaporod\u00e1s\u00e1t \u00e9s terjed\u00e9s\u00e9t. A lapatinib alkalmaz\u00e1sa sor\u00e1n \u00e1ltal\u00e1ban meghat\u00e1rozott ciklusokat k\u00f6vetnek, amelyek sor\u00e1n a gy\u00f3gyszert or\u00e1lis \u00faton, naponta egy alkalommal …<\/p>\n

    Lapatinib ciklus: Hat\u00e9konys\u00e1g \u00e9s alkalmaz\u00e1s<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/posts\/610606"}],"collection":[{"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/comments?post=610606"}],"version-history":[{"count":1,"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/posts\/610606\/revisions"}],"predecessor-version":[{"id":610607,"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/posts\/610606\/revisions\/610607"}],"wp:attachment":[{"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/media?parent=610606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/categories?post=610606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/onle2023.excelentacj.ro\/index.php\/wp-json\/wp\/v2\/tags?post=610606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}